EUVIMEDEUVIMED entdecken
Open Access

In‐Outside Hypoxia Remodeling Strategy Triggers Ferroptosis to Boost TACE Therapy in Hepatocellular Carcinoma

Gaofeng Shu, Kai Li, Shiji Fang iD, Qianhui He, Jiayi Shi, Peiyao Liu, Fazong Wu, Min Xu, Weiqian Chen, Kai Yan, Jin Su, Jiansong Ji iD und 1 weitere

Small · 2026

DOI: 10.1002/smll.74482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Gaofeng Shu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biote…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Ferroptosis. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Zhejiang Medicine and Health science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic efficacy of transarterial chemoembolization (TACE) is strongly limited by the hypoxic and immunosuppressive tumor microenvironment (TME). Herein, monodisperse perfluorooctyl bromide (PFOB)‐loaded fucoidan/gelatin microspheres (P@FGMS) with excellent oxygen‐carrying capability were prepared for enhanced TACE treatment of hepatocellular carcinoma (HCC). It was found that the introduction of fucoidan endowed P@FGMS with excellent electrostatic affinity for positively charged doxorubicin (DOX) and metformin (MET), enabling their efficient co‐loading and sustained release. The resulting drug‐loaded microspheres (DMP@FGMS) largely enhanced chemotherapy sensitivity through an in‐outside hypoxia remodeling strategy: the supplement of exogenous O 2 via PFOB and inhibition of intracellular oxygen consumption by MET. Notably, DMP@FGMS could not only modulate hypoxic TME, but also generate intracellular ROS and disrupt the redox homeostasis, thereby triggering cancer ferroptosis. Moreover, DMP@FGMS effectively remodeled the immunosuppressive TME by alleviating tumor hypoxia and inducing immunogenic cell death (ICD), thereby enhancing CD8 + T cell infiltration while reducing immunosuppressive cell populations. Consequently, DMP@FGMS could effectively suppress tumor growth in an orthotopic HCC rat model, with this effect further potentiated by combination with immune checkpoint blockade therapy. Therefore, this study demonstrates that DMP@FGMS is a potent embolic agent capable of remodeling the hypoxic/immunosuppressive TME, representing a promising strategy for TACE treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticFerroptosisAnimalsMicrospheresDoxorubicinRatsCell Line, TumorTumor MicroenvironmentHumansPolysaccharidesFluorocarbonsReactive Oxygen SpeciesMetforminGelatinHydrocarbons, Brominated

Stichwörter der Autor:innen

ferroptosishepatocellular carcinomahypoxiaimmunogenic cell deathimmunotherapymonodisperse microspherestransarterial chemoembolization

Substanzen

DoxorubicinPolysaccharidesfucoidanFluorocarbonsReactive Oxygen SpeciesMetforminGelatinperflubronHydrocarbons, Brominated

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University,…
  • Department of Radiology, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
  • Cancer Center, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
  • Department of Neonatology, Shanghai, China.
  • Department of Vascular Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
  • College of Pharmacy, Heilongjiang Provincial Key Laboratory of New Drug Development and Pharmacotoxicological Evaluation, Jiamusi University, Jiamusi, China.

ORCID-Profile: Shiji Fang, Jiansong Ji, Minjiang Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Zhejiang Medicine and Health science and Technology Project
  • Key Research and Development project of Lishui City

Zitieren

APA

Shu, G., Li, K., Fang, S., He, Q., Shi, J., Liu, P., Wu, F., Xu, M., Chen, W., Yan, K., Su, J., Ji, J., & Chen, M. (2026). In‐Outside Hypoxia Remodeling Strategy Triggers Ferroptosis to Boost TACE Therapy in Hepatocellular Carcinoma. Small. https://doi.org/10.1002/smll.74482

Vancouver

Shu G, Li K, Fang S, He Q, Shi J, Liu P, et al. In‐Outside Hypoxia Remodeling Strategy Triggers Ferroptosis to Boost TACE Therapy in Hepatocellular Carcinoma. Small. 2026. doi:10.1002/smll.74482

BibTeX
@article{Shu2026,
  author = {Shu, Gaofeng and Li, Kai and Fang, Shiji and He, Qianhui and Shi, Jiayi and Liu, Peiyao and Wu, Fazong and Xu, Min and Chen, Weiqian and Yan, Kai and Su, Jin and Ji, Jiansong and Chen, Minjiang},
  title = {In‐Outside Hypoxia Remodeling Strategy Triggers Ferroptosis to Boost TACE Therapy in Hepatocellular Carcinoma},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.74482}
}
Kostenlos starten →